Sector: Health Care
Director information for REVVITY INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Alexis P. Michas | Managing Partner, Juniper Investment Company, LLC | 68 | ["Strategic & Executive Leadership","Finance/Capital Markets","Investment Management","Public Company Board Experience"] | [] | 2026 |
| Frank Witney, PhD | Former Chief Executive Officer, Affymetrix, Inc. | 72 | ["Strategic & Executive Leadership","Mergers and Acquisitions","Public Company Board Experience"] | ["Compensation & Benefits","Nominating & Corporate Governance"] | 2026 |
| Michael A. Klobuchar | Chief Operating Officer, Eikon Therapeutics, Inc. | 50 | ["Strategic & Executive Leadership","CEO of Public Company","Mergers and Acquisitions","International Experience","Industry Experience","Public Company Board Experience"] | ["Audit"] | 2026 |
| Michelle McMurry-Heath, MD, PhD | Founder and Chief Executive Officer, BioTechquity Clinical | 56 | ["CEO of Public Company","Mergers and Acquisitions","International Experience","ESG Experience"] | ["Compensation & Benefits"] | 2026 |
| Michel Vounatsos | Former Chief Executive Officer, Biogen Inc. | 64 | ["Strategic & Executive Leadership","Public Company Board Experience"] | ["Audit","Nominating & Corporate Governance (Chair)"] | 2026 |
| Pascale Witz | Founder and President of PWH Advisors | 59 | ["Strategic & Executive Leadership","Mergers and Acquisitions","Public Company Board Experience"] | ["Audit","Compensation & Benefits"] | 2026 |
| Peter Barrett, PhD | Partner, Atlas Venture | 73 | ["Strategic & Executive Leadership","CEO of Public Company","Finance/Capital Markets","Investment Management","Mergers and Acquisitions","International Experience","Industry Experience","Public Company Board Experience"] | ["Compensation & Benefits (Chair)","Nominating & Corporate Governance"] | 2026 |
| Prahlad R. Singh, PhD | President and CEO of Revvity | 61 | ["Strategic & Executive Leadership","Finance/Capital Markets","Mergers and Acquisitions","International Experience","Industry Experience"] | [] | 2026 |
| Samuel R. Chapin | Retired Executive Vice Chair, Bank of America Merrill Lynch | 68 | ["Strategic & Executive Leadership","Finance/Capital Markets","Investment Management","Mergers and Acquisitions","Public Company Board Experience"] | ["Audit (Chair)","Nominating & Corporate Governance"] | 2026 |
| Sophie V. Vandebroek, PhD | Former Vice President, Emerging Technology Partnerships, IBM Corporation | 64 | ["Mergers and Acquisitions","International Experience","Industry Experience","Public Company Board Experience","ESG Experience"] | ["Audit"] | 2026 |
